NEW

Johnson & Johnson to Acquire Shockwave Medical

Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, corresponding to an enterprise value of...

Medline Expands Catheter Portfolio

Medline and Consure Medical have announced a new agreement for Medline to exclusively distribute the QiVi MEC male external urine management device to help guard against catheter-associated urinary tract infections (CAUTI) and incontinence-associated dermatitis (IAD)....

FDA Clears Single-use Flexible Ureteroscope

Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later...

Brainlab, Fujifilm Offer Advanced Neurosurgery Capabilities

FUJIFILM Healthcare Americas Corporation and Brainlab recently announced that Brainlab will be the exclusive U.S. distributor of ARIETTA Precision Ultrasound for neurosurgery applications to be utilized with Brainlab’s surgical navigation systems. ARIETTA Precision,...

Teleflex Introduces CleanSweep Technology

Teleflex Inc., a provider of medical technologies for critical care and surgery, showcased its portfolio of products for respiratory care at the 70th anniversary of the American Association for Respiratory Care (AARC) Congress, October 4-7, 2017 in Indianapolis.

At the congress, Teleflex introduced the CleanSweep Closed Suction System (CSS), a closed suction catheter designed to remain in-line for up to 72 hours. Unlike standard closed suction catheters, the CleanSweep System provides enhanced secretion removal through a dual operation of balloon sweeping technology with suction collection.

In addition, Teleflex highlighted its turnkey solution for High Flow Nasal Cannula Therapy (HFNCT), a new standard of care for patients with acute hypoxemic respiratory failure. HFNCT has grown in usage 20 percent year over year and studies published in The New England Journal of Medicine suggest treatment with HFNCT, compared to non-invasive ventilation or standard oxygen masks, can improve survival rates among patients with Acute Hypoxemic Respiratory Failure.

“Teleflex is committed to providing progressive technologies that meet the evolving needs of our customers,” said James Ferguson, president of the Teleflex respiratory division. “The introduction of the CleanSweep System highlights our dedication to connecting clinicians with technology in a way that improves clinical practice and advances patient outcomes.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X